Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd. is a blank check company incorporated on April 27, 2023, in the Cayman Islands. Its purpose is to complete a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company aims to acquire small-cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Its search for target businesses is not limited to a specific geographic region. On December 6, 2023, Aimei Health completed its initial public offering (IPO) of 6,000,000 units, each priced at $10.00, generating gross proceeds of $60,000,000. Each IPO Unit consists of one ordinary share with a $0.0001 par value and one right to receive one-fifth (1/5) of one ordinary share upon the completion of an initial business combination. The underwriters exercised their over-allotment option in full, purchasing an additional 900,000 units, which generated total proceeds of $9,000,000. Simultaneously with the IPO closing on December 6, 2023, the company completed a private placement with Aimei Investment Ltd. (the "Sponsor") for 332,000 units, generating total proceeds of $3,320,000. These Private Units are identical to the Public Units sold in the IPO.